PharmaShots | Incisive News in 3 Shots

Subscribe Now

HRR-Mutated Metastatic Castration-Resistant Prostate

AstraZeneca's Lynparza (olaparib) Receives the US FDA's Priority Review for HRR-Mutated Metastatic Castration-Resistant Prostate Cancer

AstraZeneca's Lynparza (olaparib) Receives the US FDA's Priority Review for HRR-Mutated Metastatic Castration-Resistant Prostate C...

January 20, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us